Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on LaLeuDH. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113106078B reveals novel LaLeuDH mutants enabling 1.5M substrate tolerance and coenzyme-free synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.